Cosmo Pharmaceuticals saw the highest growth of 399% in patent filings and 499% in grants in August in Q3 2023. Compared to Q2 2023, Q3 2023 saw an increase in patent filings by 99% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of Cosmo Pharmaceuticals’s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Cosmo Pharmaceuticals has been focused on protecting inventions in United States(US) with 3 publications in Q3 2023

The United States(US) Patent Office dominates the patent filings and grants with nearly 40% filings and 14% grants. The United States(US), Denmark(DK), European Patent Office(EPO), and Spain(ES) patent Office are among the top ten patent offices where Cosmo Pharmaceuticals is filings its patents. Among the top granted patent authorities, Cosmo Pharmaceuticals has 14% of its grants in United States(US), 14% in Spain(ES), and 14% in Finland(FI).

Johnson & Johnson could be the strongest competitor for Cosmo Pharmaceuticals

Johnson & Johnson and Sanofi secured the top positions according to recent patent publication data.

Patents related to healthtech and artificial intelligence lead Cosmo Pharmaceuticals's portfolio

Cosmo Pharmaceuticals has the highest number of patents in healthtech followed by, artificial intelligence and data science. For healthtech, nearly 22% of patents were filed and 22% of patents were granted in Q3 2023.

Active and passive safety related patents lead Cosmo Pharmaceuticals portfolio followed by mos micro (mpu, mcu & dsp), and digital signal processors(dsp)

Cosmo Pharmaceuticals has highest number of patents in active and passive safety followed by mos micro (mpu, mcu & dsp), digital signal processors(dsp), image management and healthcare it. For active and passive safety, nearly 15% of patents were filed and 15% of patents were granted in Q3 2023.

For comprehensive analysis of Cosmo Pharmaceuticals's filings and grants, buy the databook here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.